Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 NCCN Annual Conference
European Association of Urology Congress 2024
AACR Annual Meeting 2024
2024 Miami Breast Cancer Conference
2024 Society of Surgical Oncology Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
TAT 2018%3A Targeted Anticancer Therapies,TAT 2018%3A Targeted Anticancer Therapies
«
1
»
Advertisement
Advertisement
Apr
20
Today In Oncology
Alectinib Approved as Adjuvant Treatment for ALK-Positive Non–Small Cell Lung Cancer
Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC
Accelerated Aging May Be a Risk Factor for Early-Onset Cancers in Younger Generations
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
Novel SPECT/CT Imaging Technique Under Study in Prostate Cancer
View More
Advertisement
